MicroPort CardioFlow Medtech Corporation (HKG:2160)

Hong Kong · Delayed Price · Currency is HKD

1.110

0.00 (0.00%)

Jul 31, 2026, 4:08 PM HKT

HKG:2160 Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	57.04	57.04	50.81	47.41	36.4	31.61
Revenue Growth	12.28%	12.28%	7.15%	30.28%	15.14%	98.56%
Gross Profit	37.06	37.06	35.3	32.43	23.51	18.69
Operating Income	-19.69	-19.69	-19.37	-56.67	-53.04	-28.31
Net Income	-18.82	-18.82	-6.95	-66.5	-65.88	-28.85
Earnings Per Share	-0.04	-0.04	-0.01	-0.14	-0.14	-0.06
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Crm Business	5.73	5.73	-	-	-	-
structural heart disease business	51.31	51.31	50.81	47.41	36.4	31.61
Total	57.04	57.04	50.81	47.41	36.4	31.61

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	189.32	189.32	189.2	250.42	301.43	380.63
Total Debt	232.24	232.24	10.69	9.94	13.84	19.78
Net Cash (Debt)	-42.92	-42.92	178.51	240.48	287.59	360.85
Net Cash Growth	-	-	-25.77%	-16.38%	-20.30%	288.82%
Net Cash Per Share	-0.09	-0.09	0.38	0.51	0.61	0.77

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-3.32	-3.32	-15.4	-29.19	-26.46	-25.42
Capital Expenditures	-34.89	-34.89	-22.02	-3.94	-6.66	-13.13
Free Cash Flow	-38.21	-38.21	-37.42	-33.13	-33.13	-38.55
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.97%	64.97%	69.48%	68.39%	64.59%	59.11%
Operating Margin	-34.51%	-34.51%	-38.13%	-119.52%	-145.74%	-89.54%
Pretax Margin	-31.62%	-31.62%	-12.80%	-137.88%	-179.78%	-90.96%
Profit Margin	-32.99%	-32.99%	-13.68%	-140.25%	-181.01%	-91.26%
FCF Margin	-66.99%	-66.99%	-73.65%	-69.87%	-91.02%	-121.97%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	38.21	-	-	-	-
PS Ratio	3.18	17.35	4.16	10.55	22.16	37.74